Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

58.90
Delayed Data
As of 3:59pm ET
 -0.03 / -0.05%
Today’s Change
37.35
Today|||52-Week Range
60.00
+52.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues0.000.000.006.3M
 
 
Cost of Goods Sold0.000.000.0061.0K
 
 
Depreciation And Amortization408.0K492.0K489.0K589.0K
 
 
 
 
 
 
Operating ExpensesGross Income-408.0K-492.0K-489.0K5.7M
 
 
 
 
 
General Expenses38.0M45.8M79.4M63.0M
 
 
 
 
 
Research And Development20.9M22.6M51.9M21.9M
 
 
 
 
 
Total Operating Expenses38.4M46.3M79.9M63.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.4M-46.3M-79.9M-57.3M
 
 
 
 
 
Interest Expense On Debt0.000.000.004.8M
 
 
Other Expenses844.0K863.0K879.0K881.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-36.9M-44.7M-78.3M-60.0M
 
 
 
 
 
Net Income-36.9M-44.7M-78.3M-60.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS86.8M86.9M87.3M88.1M
 
 
 
 
 
Shares To Calculate EPS Diluted86.8M86.9M87.3M88.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.51-$0.90-$0.68
 
 
 
 
 
EPS Diluted-$0.43-$0.51-$0.90-$0.68